Single-agent ibrutinib in relapsed or refractory follicular lymphoma: a phase 2 consortium trial.
published in: Blood
date of publication: 2017-10-26
language: English
main subject: phase II clinical trial, ibrutinib, follicular lymphoma
Cites articles 37
- 2016-06-10
- 2013-03-29
Date
Title
Article - wd:Q47709959